Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 557, doi. 10.1007/s00262-002-0321-3
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2002 AND VI 51 AND IP 10
Results: 7
1
2
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 532, doi. 10.1007/s00262-002-0313-3
- By:
- Publication type:
- Article
3
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 539, doi. 10.1007/s00262-002-0315-1
- By:
- Publication type:
- Article
4
A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 565, doi. 10.1007/s00262-002-0312-4
- By:
- Publication type:
- Article
5
Characterisation of tumour-associated antigens in colon cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 574, doi. 10.1007/s00262-002-0322-2
- By:
- Publication type:
- Article
6
Rapid blood clearance of injected mouse IgG2a in SCID mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 547, doi. 10.1007/s00262-002-0319-x
- By:
- Publication type:
- Article
7
Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 521, doi. 10.1007/s00262-002-0309-z
- By:
- Publication type:
- Article